Ligand Pharmaceuticals Incorporated (OTC: LGND) said cancer drug ONTAK benefits patients with relapsed/refractory T-cell and B-cell non-Hodgkin's lymphoma according to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE